4.125
Schlusskurs vom Vortag:
$3.94
Offen:
$3.95
24-Stunden-Volumen:
2.20M
Relative Volume:
0.47
Marktkapitalisierung:
$1.46B
Einnahmen:
$9.68M
Nettoeinkommen (Verlust:
$-250.64M
KGV:
-2.9468
EPS:
-1.3998
Netto-Cashflow:
$-89.83M
1W Leistung:
+26.94%
1M Leistung:
+24.27%
6M Leistung:
+31.39%
1J Leistung:
+232.72%
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PGEN
Precigen Inc
|
4.125 | 1.39B | 9.68M | -250.64M | -89.83M | -1.3998 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.35 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
758.57 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
746.09 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.60 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
INSM
Insmed Inc
|
164.88 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Precigen (PGEN) Is Up 7.4% After Surging Revenue And Wider 2025 Losses Are Reported – Has The Bull Case Changed? - simplywall.st
Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo
PGEN Should I Buy - Intellectia AI
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 4,772,781 Shares of Stock - MarketBeat
PGEN SEC FilingsPrecigen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PGEN.O Technical Analysis & Stock Price Forecast - Intellectia AI
PGEN PE Ratio & Valuation, Is PGEN Overvalued - Intellectia AI
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Precigen gains after 2025 results on Papzimeos' outlook - MSN
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 earnings call transcript - MSN
PGEN.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk - Stock Titan
Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake - Stock Titan
Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat - MarketBeat
Precigen (NASDAQ:PGEN) Stock Price Up 11.2%What's Next? - MarketBeat
These analysts boost their forecasts on Precigen following Q4 results - MSN
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 - StreetInsider
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Precigen (NASDAQ:PGEN) Shares Down 9%Time to Sell? - MarketBeat
HC Wainwright Estimates Precigen's Q1 Earnings (NASDAQ:PGEN) - MarketBeat
Precigen (PGEN) Is Up 11.9% After PAPZIMEOS’ Launch Shifts Focus Toward Commercial Revenue Model - simplywall.st
Precigen, Inc. (PGEN) reports Q4 loss, lags revenue estimates - MSN
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Precigen, Inc.FinancialContentStock Market - markets.financialcontent.com
HC Wainwright Has Positive Estimate for Precigen Q3 Earnings - MarketBeat
Discover Precigen And 2 Other Insider-Favored Growth Stocks - Yahoo Finance
Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? - Yahoo Finance
Precigen Earnings Call Signals Powerful Launch Momentum - TipRanks
Analyst Upgrade: Whats the beta of Precigen Inc stockMarket Weekly Review & Fast Gain Stock Tips - baoquankhu1.vn
Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has) - Seeking Alpha
These Analysts Boost Their Forecasts On Precigen Following Q4 Results - Benzinga
Precigen (PGEN) Soars 26% Despite Missed Revenue Estimates - gurufocus.com
Precigen (NASDAQ:PGEN) Shares Gap Up Following Analyst Upgrade - MarketBeat
Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss - gurufocus.com
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Price Target Raised to $9.00 at Citizens Jmp - MarketBeat
PGEN: Analyst Jason N. Butler Raises Price Target to $9 | PGEN S - gurufocus.com
H.C. Wainwright raises Precigen stock price target on sales growth - Investing.com UK
Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ) - Seeking Alpha
PGEN: HC Wainwright & Co. Raises Price Target to $10.00 | PGEN S - GuruFocus
H.C. Wainwright raises Precigen stock price target on sales growth By Investing.com - Investing.com India
Precigen (NASDAQ:PGEN) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Precigen (PGEN) Reports Strong Q4 2025 with PAPZIMEOS Launch - gurufocus.com
Citizens raises Precigen stock price target on strong PAPZIMEOS sales - Investing.com UK
Citizens raises Precigen stock price target on strong PAPZIMEOS sales By Investing.com - Investing.com Australia
Precigen Achieves First Commercial Revenue in 2025 with FDA Approval and Strong US Launch of PAPZIMEOS for RRP - Minichart
Precigen Inc. 2025 Annual Report: Papzimeos Launch, UltraCAR-T & AdenoVerse Platform, Clinical Pipeline, Risks, and Competitive Landscape 33 34 35 38 40 54 - Minichart
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):